Nepafenac
ATC S01BC10 · 10 markets · 28 records
Nepafenac
Forms
GB 4 records · 2 strengths
- 3 mgliquidNevanac 1mg/ml eye drops
- 1 mgliquidNevanac 1mg/ml eye drops
ES 4 records · 2 strengths
- 1 mg/1 mLliquidNEVANACNEVANAC 3mg/ml
- 3 mg/1 mLliquidNEVANAC 3mg/ml
US 3 records · 2 strengths
AU 3 records · 2 strengths
- 3 mg/mLliquidILEVRO nepafenac 0.3% eye drops, suspension, bottleILEVRO nepafenac 0.3% eye drops, suspension, oval bottle
Records without a stated strength · 1 ILEVRO
CA 2 records · 2 strengths
TW 2 records · 2 strengths
- 3 mgliquidILEVRO 3 mg/mL Eye Drops, Suspension以利視點眼懸液劑0.3%
Records without a stated strength · 1 Nevanac Ophthalmic suspension 0.1%、納衛視點眼懸液劑 0.1%
HK 2 records · 1 strengths
Records without a stated strength · 1 NEVANAC OPHTHALMIC SUSP 0.1%W/V、NEVANAC OPHTHALMIC SUSPENSION 0.1% W/V
SG 1 records · 1 strengths
- 1 mg/mLliquidNevanac® Eye Drops Suspension 1 mg/ml
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 NEVANAC
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.